Raise closed, search for fresh raises on Seedstage

Salt Lake City, UT

Expanding AI-powered surgical imaging technology to improve precision and safety in adult and pediatric procedures.

• FDA-cleared solution: The nView s1 system is authorized for pediatric and adult surgical use.
• Proven clinical use: Deployed in over 500 surgeries at leading U.S. pediatric hospitals.
• AI-driven imaging: Enables real-time, low-dose 3D imaging in the operating room.
• Recurring revenue model: Includes surgical disposables and service contracts alongside equipment placements.
• Strategic growth plan: Aims to expand into the $6B U.S. adult surgical imaging market.

nView medical is raising funds to expand the reach of its FDA-cleared nView s1 system, an AI-powered 3D imaging and navigation platform designed to improve surgical precision and efficiency while minimizing radiation exposure. Initially deployed in leading pediatric hospitals, the company now seeks to scale its presence in the broader adult surgical imaging market. With over 500 surgeries performed using its system and a commercial footprint across top-tier U.S. pediatric institutions, nView medical plans to use the proceeds to accelerate R&D and commercialization efforts. The goal is to enhance access to advanced intraoperative imaging in both hospitals and ambulatory surgical centers.

With backing from venture capital, angel investors, and grant funding totaling $8.5 million, nView medical has established early traction through successful deployments and recurring revenue from surgical disposables and service contracts. The company’s technology addresses a critical challenge in surgical imaging: the trade-off between speed, radiation exposure, and 3D imaging quality. By integrating AI to generate real-time, low-dose 3D images, nView offers a solution with potential applications across a total addressable U.S. medical imaging market estimated at $10 billion. The funds from this raise are intended to position nView medical for growth beyond pediatrics into the larger adult surgical market, broadening its impact on patient outcomes and workflow optimization.

Company Info

nView medical provides AI-powered 3D imaging systems for surgery that reduce radiation and improve precision.

nView medical develops AI-powered 3D imaging systems designed to enhance surgical precision, workflow efficiency, and patient safety. Its flagship product, the nView s1, provides real-time, high-resolution 3D imaging with low radiation exposure and has received FDA 510(k) clearance. Used in over 500 surgeries at top U.S. pediatric hospitals such as Stanford Children’s and Texas Scottish Rite, the technology addresses the limitations of traditional 2D and high-radiation 3D scans in the operating room.

With more than $8.5M in venture capital, grants, and angel investments, nView medical has generated over $1M in revenue and holds 8 granted patents. The company is initially focused on the $250M U.S. pediatric imaging market and plans to expand into the $6B U.S. adult surgical market. Revenue streams include equipment sales, surgical disposables, and service contracts. Beyond orthopedic surgeries, the technology has potential applications across the $10B U.S. X-ray imaging market, including diagnostics and point-of-care scenarios.